TrialScientific reports2025

Vonoprazan attenuates proteinuria in diabetic kidney disease through potential direct renal mechanism.

Rabab Mahmoud Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.